Clinical Trial

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess feasibility, safety and preliminary efficacy of Extracorporeal Photopheresis in the treatment of active diffuse cutaneous systemic sclerosis (dcSSc). This pilot study will help to determine if further study (a RCT) is justified.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-07-22; most recent amendment 2025-03-10.
Trial Details
NCT Number NCT04986605
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Mallinckrodt
Conditions Diffuse Cutaneous Systemic Sclerosis
Enrollment 15 participants
Start Date 2025-07-01
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2025-03-13